Physician profile
Leonard Brabson
NPI 1689736431
$1,752.24
in general payments reported to CMS, 2019-2025
21 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $52.26 · 2021: $284 · 2022: $470 · 2023: $313 · 2024: $286 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $591.17 | 2019-2025 | Lo Loestrin Fe, Ubrelvy, Orilissa |
| Hologic Sales and Service, LLC | $230.26 | 2019-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Mayne Pharma Commercial LLC | $133.49 | 2021-2023 | |
| Therapeuticsmd, INC. | $102.10 | 2019-2022 | |
| Sage Therapeutics, LLC | $100.60 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $81.93 | 2023-2025 | Veozah, Myrbetriq |
| Agile Therapeutics, INC. | $79.18 | 2021-2022 | |
| Innovation Technologies INC | $76.84 | 2024 | Irrisept |
| Myovant Sciences INC. | $56.61 | 2022 | |
| Exeltis, USA INC. | $53.92 | 2021-2022 | |
| Daiichi Sankyo INC. | $45.83 | 2022-2024 | Injectafer |
| Coopersurgical, INC. | $38.04 | 2021-2024 | Endosee |
| Pfizer INC. | $37.23 | 2025 | |
| Mylan Pharmaceuticals INC. | $22.76 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $16.69 | 2023 | Gemtesa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien Lp | $16.42 | 2019 | |
| Phathom Pharmaceuticals, INC. | $16.09 | 2024 | Voquezna |
| Shield Therapeutics INC | $13.83 | 2024 | |
| Sanara Medtech INC. | $13.47 | 2021 | |
| Organon LLC | $13.33 | 2022 | |
| Allergan, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Brabson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.